238 related articles for article (PubMed ID: 36171573)
21. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
22. TGF-β & BMP receptors endoglin and ALK1: overview of their functional role and status as antiangiogenic targets.
Jonker L
Microcirculation; 2014 Feb; 21(2):93-103. PubMed ID: 25279424
[TBL] [Abstract][Full Text] [Related]
23. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
24. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
25. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
[TBL] [Abstract][Full Text] [Related]
27. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
[TBL] [Abstract][Full Text] [Related]
28. Potential roles of BMP9 in liver fibrosis.
Bi J; Ge S
Int J Mol Sci; 2014 Nov; 15(11):20656-67. PubMed ID: 25393508
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
Haines P; Hant FN; Lafyatis R; Trojanowska M; Bujor AM
J Cell Mol Med; 2012 Sep; 16(9):2238-46. PubMed ID: 22277251
[TBL] [Abstract][Full Text] [Related]
30. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
31. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.
Baeyens N; Larrivée B; Ola R; Hayward-Piatkowskyi B; Dubrac A; Huang B; Ross TD; Coon BG; Min E; Tsarfati M; Tong H; Eichmann A; Schwartz MA
J Cell Biol; 2016 Sep; 214(7):807-16. PubMed ID: 27646277
[TBL] [Abstract][Full Text] [Related]
32. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
33. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1-Endoglin-Smad1/5/9 signalling.
Yang C; Sun M; Yang Y; Han Y; Wu X; Wu X; Cao H; Chen L; Lei Y; Hu X; Chen Y; Zeng Z; Li J; Shu X; Yang Z; Lu K; Li Y; Wang X; Yi B
Eur J Clin Invest; 2024 Apr; ():e14212. PubMed ID: 38591651
[TBL] [Abstract][Full Text] [Related]
34. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
35. BMP-9 and LDL crosstalk regulates ALK-1 endocytosis and LDL transcytosis in endothelial cells.
Tao B; Kraehling JR; Ghaffari S; Ramirez CM; Lee S; Fowler JW; Lee WL; Fernandez-Hernando C; Eichmann A; Sessa WC
J Biol Chem; 2020 Dec; 295(52):18179-18188. PubMed ID: 33097593
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
37. Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.
Wei Z; Salmon RM; Upton PD; Morrell NW; Li W
J Biol Chem; 2014 Nov; 289(45):31150-9. PubMed ID: 25237187
[TBL] [Abstract][Full Text] [Related]
38. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
[TBL] [Abstract][Full Text] [Related]
39. Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1.
Saito T; Bokhove M; Croci R; Zamora-Caballero S; Han L; Letarte M; de Sanctis D; Jovine L
Cell Rep; 2017 May; 19(9):1917-1928. PubMed ID: 28564608
[TBL] [Abstract][Full Text] [Related]
40. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
